Cost & Delivery Methods
NAD+ Injections vs IV Drips: Which Is Worth Your Money?
IV NAD+ drips cost $250 to $1,000+ per session and take 2-4 hours. Subcutaneous injections deliver near-identical bioavailability at $60 in 5 minutes. Here is an honest comparison of the science, cost, and clinical reality.
Medically reviewed by Missy Zammichieli, DNP, APRN, FNP-BC · April 1, 2026
THE IV NAD+ INDUSTRY: WHAT YOU ARE ACTUALLY PAYING FOR
The IV NAD+ market has exploded over the past five years. Drip bars, IV lounges, mobile IV services, and medspas now offer NAD+ infusions in most major metropolitan areas. The experience typically looks like this: you sit in a designer chair or lie on a treatment bed while NAD+ dissolved in saline drips into your vein through an IV line over 2-4 hours. The price ranges from $250 at the low end to $1,000 or more at premium locations. Some facilities offer "NAD+ packages" of multiple sessions for $3,000 to $5,000+.
The marketing is sophisticated. Luxury aesthetics, celebrity endorsements, claims about "reversing aging," "detoxing the brain," and "cellular rejuvenation." The atmosphere is intentionally premium. Ambient lighting, complimentary beverages, blankets, tablets for entertainment during your 3-hour drip. You are paying for an experience as much as a medical treatment.
There is nothing inherently wrong with IV NAD+ delivery. It works. NAD+ delivered intravenously enters the bloodstream directly with 100% bioavailability. But there are important questions that the industry's marketing does not encourage you to ask: Is 100% bioavailability meaningfully better than 90-95%? Does the higher peak plasma concentration from IV delivery produce better outcomes than subcutaneous delivery? And does the price reflect the pharmacology, or does it reflect the overhead and branding?
We are going to answer those questions honestly.
BIOAVAILABILITY: THE NUMBERS THAT MATTER
Bioavailability is the percentage of an administered substance that reaches systemic circulation and is available for biological activity. It is the metric that determines how much of what you put into your body actually does something. Here is how the three main NAD+ delivery methods compare:
Intravenous (IV): ~100% Bioavailability
NAD+ is delivered directly into the bloodstream. No absorption barrier. No first-pass metabolism. The full dose reaches systemic circulation. IV delivery also produces the highest peak plasma concentrations because the entire dose enters the bloodstream over a compressed timeframe (typically 2-4 hours for a slow drip). This high peak is also what causes the side effects: rapid NAD+ flooding triggers flushing, nausea, chest tightness, and warmth. These effects are dose-rate dependent and managed by slowing the drip, which extends treatment time further.
Subcutaneous (SubQ) Injection: ~90-95% Bioavailability
NAD+ is injected into the fat layer just under the skin (typically the abdomen or upper arm). The NAD+ is absorbed through subcutaneous capillaries into systemic circulation over 15-30 minutes. Because absorption is gradual, peak plasma concentrations are lower than IV but sustained over a longer window. This gradual absorption profile means significantly fewer side effects. Most patients experience mild warmth at the injection site and nothing more. The entire procedure takes about 5 minutes.
Oral NMN/NR: ~2-10% Bioavailability
Oral NAD+ precursors (NMN and NR) must survive gastric acid, be absorbed through the intestinal lining, undergo first-pass metabolism in the liver, and then be enzymatically converted through multiple steps into NAD+ in target tissues. At each stage, a portion of the dose is lost. Published bioavailability estimates for oral NMN range widely, but the effective conversion to tissue-level NAD+ is a fraction of the ingested dose. This is not to say oral precursors are useless, but the efficiency gap compared to injectable delivery is substantial.
The critical point: The difference between 100% (IV) and 90-95% (SubQ) bioavailability is 5-10%. That is not zero, but it is small. The question is whether a 5-10% bioavailability advantage justifies a 4-16x price premium and a 24-48x time commitment. For the vast majority of patients and clinical use cases, the answer is no. You are paying for the last 5-10% of absorption at a cost that makes no pharmacological sense.
TIME: THE COST MOST PEOPLE FORGET
Time is a finite resource, and the time comparison between IV and SubQ NAD+ is dramatic.
IV NAD+ Drip
Treatment time: 2-4 hours per session. Some clinics push infusions faster (60-90 minutes) but this dramatically increases side effects. Standard protocol at most IV lounges is 2-3 hours for a 250-500mg dose.
Travel and booking: Add 30-60 minutes for travel to the facility plus check-in. Most IV facilities require advance booking.
Recovery: Some patients feel fatigued or mildly nauseous for 30-60 minutes after an infusion, particularly at higher doses.
Total time commitment per session: 3-5 hours, realistically.
SubQ NAD+ Injection
Treatment time: Approximately 5 minutes. Walk in, injection administered, walk out.
Recovery: Mild warmth at injection site for some patients. No downtime. No nausea. Patients routinely schedule injections during lunch breaks or on the way to the gym.
Total time commitment per session: 15-20 minutes including travel if you are local to Park Ridge.
Over 12 weeks (weekly sessions): IV NAD+ = 36-60 hours spent in treatment. SubQ NAD+ = 3-4 hours total. That is 32-56 hours of your life reclaimed. If your time is worth anything at all, the SubQ efficiency advantage compounds rapidly.
COST COMPARISON: 3-MONTH ANALYSIS
Money is a legitimate factor in health decisions, and the cost differential between IV and SubQ NAD+ is substantial. Here is an apples-to-apples comparison over a standard 12-week protocol.
IV NAD+ (Weekly, 12 Weeks)
Price range: $250-1,000 per session (market average varies by city and facility)
12-week cost: $3,000 - $12,000
Plus: travel costs, time off work, parking. Some facilities charge extra for "premium" NAD+ formulations or add-on vitamins mixed into the drip.
SubQ NAD+ at Moonshot (Weekly, 12 Weeks)
Price: $60 per injection
12-week cost: $720
Hormone optimization members receive 1 injection/month included in their membership, which reduces the effective cost further. No hidden fees. No add-on pressure.
Oral NMN Supplement (Daily, 12 Weeks)
Price: $1-3 per day for quality NMN (250-500mg)
12-week cost: $84 - $252
Cheapest option but 2-10% bioavailability means most of what you swallow never becomes usable NAD+ in your tissues. The cost per unit of effectively delivered NAD+ may actually be higher than SubQ when you account for absorption losses.
The math: SubQ NAD+ at Moonshot costs 6-17% of what IV drip bars charge for a 12-week protocol. The bioavailability difference is 5-10%. You are getting 90-95% of the pharmacological benefit at 6-17% of the cost. The savings over 3 months ($2,280-$11,280) could fund a complete hormone optimization program, comprehensive blood panels, peptide therapy, or all three. From a pure ROI perspective, SubQ NAD+ is not even close. It wins.
SIDE EFFECTS: THE COMFORT FACTOR
NAD+ is the same molecule regardless of delivery method. But how that molecule enters your bloodstream dramatically affects the experience.
IV NAD+ Side Effects
IV NAD+ infusions commonly produce nausea, chest tightness, flushing, warmth, and a sensation sometimes described as "chest pressure" or "heaviness." These effects are a direct result of high peak plasma concentrations. When large amounts of NAD+ flood the bloodstream rapidly, it triggers a transient physiological response. The effects are not dangerous, but they are unpleasant for many patients.
The standard management is to slow the drip rate, which reduces peak concentrations but extends treatment time. Some patients tolerate it well. Others find the 2-4 hours of mild-to-moderate discomfort to be a significant deterrent. A subset of patients find IV NAD+ intolerable at any drip rate and discontinue therapy.
There is also the inherent risk of IV access: bruising, hematoma, infection at the insertion site (rare but real), and the discomfort of having a needle in your vein for hours. These risks are low with proper technique but they are not zero.
SubQ NAD+ Side Effects
Subcutaneous injection side effects are minimal. The most common report is mild warmth or slight redness at the injection site, which resolves within 15-30 minutes. Because absorption is gradual through subcutaneous capillaries, peak plasma concentrations are lower than IV, which means the nausea, chest tightness, and flushing that characterize IV delivery are rare to absent with SubQ.
The injection itself is a small-gauge needle into the fat layer of the abdomen or upper arm. Comparable to an insulin injection. Most patients describe it as a brief pinch and nothing more. No IV line, no bruising risk at a venipuncture site, no hours of sitting still.
Clinical reality: In our practice, patient compliance with SubQ NAD+ is high because it is fast, easy, and well-tolerated. Compliance is the single most important factor in any therapy. The best treatment protocol in the world is worthless if the patient stops showing up because the experience is unpleasant. SubQ NAD+ removes the barriers that make IV NAD+ a difficult long-term commitment.
MEDICAL OVERSIGHT: THE VARIABLE MOST PEOPLE IGNORE
Here is where the comparison goes beyond pharmacology and into something that matters more than bioavailability percentages: the quality of the medical context in which NAD+ is delivered.
Most IV NAD+ drip bars operate as cash-pay wellness centers. Their business model is selling drips. A patient walks in, selects from a menu of infusions (NAD+, Myers' cocktail, vitamin C, glutathione), pays, receives the drip, and leaves. Medical oversight is typically limited to a brief intake form and a provider available on-site or on-call to handle adverse reactions. There is rarely comprehensive lab work, health history review, or integration with other therapies. The drip bar does not know your hormone levels, your inflammatory markers, your metabolic status, or what medications you are taking beyond what you self-report on the intake form.
This is not a criticism of every IV facility. Some are excellent. But the business model incentivizes volume and upselling drip add-ons, not comprehensive patient management.
At Moonshot Medical, NAD+ therapy exists within a complete medical framework. Every patient has comprehensive blood work. Every patient has a provider who understands their full health picture: hormone levels, metabolic markers, inflammatory status, training demands, medication interactions, and health goals. NAD+ is prescribed when it makes clinical sense as part of a broader optimization strategy, not sold as a standalone product.
The difference matters because NAD+ does not operate in isolation. Its effects are modulated by hormone status (NAD+ supports the pathways hormones activate), inflammatory load (CD38 degrades NAD+ faster when inflammation is high), metabolic health (insulin resistance impairs NAD+ utilization), and lifestyle factors. A provider who can see the full picture can prescribe NAD+ in context, dosing and timing it to complement other interventions rather than deploying it blindly.
Want NAD+ therapy with actual medical oversight? Book a consultation and we will assess whether it fits your protocol.
Book ConsultationWHEN IV NAD+ MIGHT ACTUALLY MAKE SENSE
We are not dogmatic about delivery methods. There are specific clinical scenarios where IV NAD+ may offer advantages worth the additional cost and time:
Acute Depletion States
Patients recovering from severe illness, major surgery, or prolonged hospitalization may have deeply depleted NAD+ levels. In these cases, the higher peak plasma concentrations achievable with IV delivery may provide a faster initial restoration. Think of it as jump-starting a dead battery versus trickle-charging it. Once the acute deficit is addressed, patients can transition to SubQ for maintenance.
Neurological Applications (Investigational)
Some practitioners use high-dose IV NAD+ for neurological recovery, including addiction recovery protocols and neurodegenerative conditions. The rationale is that higher peak plasma levels may improve blood-brain barrier penetration. This is an area of active investigation, not established practice. The evidence is largely anecdotal and case-report level. If you are pursuing NAD+ for a neurological indication, IV delivery under appropriate medical supervision may be worth considering while the research matures.
Patient Preference
Some patients simply prefer the IV experience. They find the 2-3 hours of forced downtime to be a welcome break from their schedule. They enjoy the ritual. They believe (whether justified or not) that the IV route makes them feel better. Patient autonomy matters. If a patient understands the cost and time differential, understands that SubQ delivers 90-95% of the bioavailability, and still prefers IV, that is a valid choice. Moonshot can refer to quality IV providers if needed.
MOONSHOT'S POSITION: INVEST THE SAVINGS WHERE THEY COMPOUND
Our recommendation is straightforward: for the vast majority of patients seeking NAD+ therapy for anti-aging, energy, athletic recovery, or cognitive performance, subcutaneous injection gives you 90-95% of the benefit at 5-10% of the cost and 5% of the time commitment.
The money you save has better uses. A 12-week protocol at Moonshot costs $720 versus $3,000-$12,000 at an IV drip bar. The $2,280-$11,280 in savings can fund:
Comprehensive Blood Work
The foundation of any optimization protocol. You cannot fix what you have not measured. A full hormone panel, metabolic markers, inflammatory markers, and nutrient levels give your provider the data to make targeted interventions. Understanding your biomarkers is step one.
Hormone Optimization
If your testosterone, thyroid, or other hormones are suboptimal, fixing that foundation will produce more noticeable results than any amount of NAD+. NAD+ supports the pathways that hormones activate. Without the hormonal signal, the fuel has less to power. NAD+ works best in an optimized system.
Peptide Therapy
BPC-157, TB-500, Sermorelin, PT-141, GHK-Cu: each targets specific therapeutic goals through mechanisms that NAD+ does not address. The savings from choosing SubQ over IV NAD+ could fund an entire peptide protocol.
DEXA Body Composition Scans
Objective measurement of lean mass, fat mass, visceral fat, and bone density. Tracks changes over time with clinical precision. The data that tells you whether your optimization protocol is actually working or just making you feel like it is.
The principle: Spend less on delivery method premiums. Invest more in comprehensive optimization. A patient getting SubQ NAD+, optimized hormones, targeted peptides, and regular lab monitoring will outperform a patient spending their entire budget on IV drips with no broader medical context. Every time. NAD+ injections available in Park Ridge.
COMMON QUESTIONS
Is IV NAD+ more effective than subcutaneous injection?
IV delivers 100% bioavailability vs 90-95% for subcutaneous. That 5-10% difference is real but clinically marginal. IV does achieve higher peak plasma concentrations, which some practitioners believe provides stronger acute effects. However, no published clinical trial has demonstrated superior long-term outcomes from IV vs SubQ NAD+ delivery. The higher peak from IV also causes more side effects (nausea, flushing, chest tightness) and requires 2-4 hours of clinic time per session.
Why do IV NAD+ drips cost so much more?
IV NAD+ pricing reflects overhead, not efficacy. IV requires a dedicated treatment room, IV supplies, nursing supervision for 2-4 hours, liability insurance for venous access procedures, and the luxury wellness branding that many IV lounges use to justify premium pricing. The NAD+ molecule itself is the same regardless of delivery method. You are paying for the experience and the infrastructure, not a meaningfully better outcome.
Are oral NAD+ supplements like NMN worth taking?
Oral NMN and NR have legitimate science behind them and can raise blood NAD+ metabolite levels. The issue is bioavailability: oral precursors undergo first-pass metabolism in the liver, and estimates suggest only 2-10% of the ingested dose reaches tissues as usable NAD+. For maintenance between injection appointments, quality oral NMN may provide supplemental benefit. As a primary NAD+ restoration strategy, the absorption math does not compare to injectable delivery. Read our full NAD+ vs NMN comparison.
How often do I need NAD+ injections?
Typical protocol is 1-2x per week during a loading phase (2-4 weeks), then weekly or biweekly for maintenance. Some patients transition to monthly maintenance once goals are achieved. At Moonshot, hormone optimization members receive 1 vitamin injection per month included in their membership. Your provider will adjust frequency based on your blood work, symptoms, and response. Full cost breakdown here.
What should I look for in a clinic offering NAD+ therapy?
Medical oversight by a licensed provider (MD, DO, NP, PA). Comprehensive intake including blood work and health history, not just a menu of drips. Transparent pricing. Willingness to discuss evidence honestly, including limitations. Integration with other therapies rather than isolated NAD+ sales. Avoid clinics that promise dramatic results, refuse to discuss the evidence base, or offer NAD+ without any medical evaluation.
References
- 1. Rajman L, Chwalek K, Sinclair DA. "Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence." Cell Metab. 2018;27(3):529-547.
- 2. Yoshino J, Baur JA, Imai S. "NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR." Cell Metab. 2018;27(3):513-528.
- 3. Yoshino M, Yoshino J, Kayser BD, et al. "Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women." Science. 2021;372(6547):1224-1229.
- 4. Airhart SE, Shireman LM, Risler LJ, et al. "An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers." PLoS One. 2017;12(12):e0186459.
- 5. Camacho-Pereira J, Tarragó MG, Chini CCS, et al. "CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism." Cell Metab. 2016;23(6):1127-1139.
- 6. Massudi H, Grant R, Braidy N, et al. "Age-associated changes in oxidative stress and NAD+ metabolism in human tissue." PLoS One. 2012;7(7):e42357.
- 7. Liao B, Zhao Y, Wang D, Zhang X, Hao X, Hu M. "Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study." J Int Soc Sports Nutr. 2021;18(1):54.
- 8. Mills KF, Yoshida S, Stein LR, et al. "Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice." Cell Metab. 2016;24(6):795-806.
- 9. Imai S, Guarente L. "NAD+ and sirtuins in aging and disease." Trends Cell Biol. 2014;24(8):464-471.
- 10. Zhu XH, Lu M, Lee BY, Ugurbil K, Chen W. "In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences." Proc Natl Acad Sci USA. 2015;112(9):2876-2881.
NAD+ INJECTIONS IN PARK RIDGE & CHICAGO'S NORTHWEST SUBURBS
Moonshot Medical and Performance
542 Busse Hwy
Park Ridge, IL 60068
- $60 per NAD+ injection — no IV drip markup
- 5 minutes — not 3 hours in a chair
- Full medical oversight — labs, hormones, integration
- Co-located with Moonshot CrossFit — integrated recovery
Serving the Northwest Suburbs
Patients come to Moonshot for NAD+ therapy from across the northwest Chicago suburbs:
- Des Plaines, Niles, Edison Park
- Morton Grove, Glenview, Skokie
- Chicago and surrounding communities
Easily accessible from all NW suburbs. Free parking on-site.
90% OF THE BENEFIT. 10% OF THE COST. 5 MINUTES.
Stop overpaying for NAD+ delivery method premiums. SubQ injection at Moonshot Medical gives you near-complete bioavailability at a fraction of the cost, integrated with comprehensive medical oversight. The savings fund the rest of your optimization protocol.
Book Consultation